MichaelRyanAbernMD

Urology • Durham, NC

Minimally Invasive Surgery, Surgical Oncology

Associate Professor of Urologic Oncology, Urologic Oncology Fellowship Director, Duke University Health System

Join to view full profile

Dr. Abern is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abern's full profile

Already have an account?

Office
40 Duke Medicine Cir
Durham, NC 27710
Phone+1 919-684-2443

Education & Training

Duke University School of MedicineUrologic Oncology Fellowship, Surgical Oncology, 2011 - 2013
Rush University Medical CenterResidency, Urology, 2006 - 2011
Rush University Medical CenterInternship, Transitional Year, 2006 - 2007
Rush Medical College of Rush University Medical CenterClass of 2006
OtherClass of 2006

Certifications & Licensure

NC State Medical License 2021 - 2025
IL State Medical License 2013 - 2023
WI State Medical License 2009 - 2011
American Board of Urology Urology

Clinical Trials

Salvage Cryotherapy in Recurrent Prostate Cancer Start of enrollment: 2007 Jan 01
Terminated
Engaging Newly Diagnosed Men About Cancer Treatment Options Start of enrollment: 2016 Apr 01
Completed
Not Applicable
International Registry for Men With Advanced Prostate Cancer (IRONMAN) Start of enrollment: 2017 Jul 21
Recruiting
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations Start of enrollment: 2018 Aug 01
Recruiting
Phase 2
A Study of Olaparib and Durvalumab in Prostate Cancer Start of enrollment: 2019 Mar 07
Terminated
Phase 2
Prostate Cancer Detection Screening MRI Protocol Start of enrollment: 2019 May 20
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

2 citations
Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial.
Hari T Vigneswaran, Martin Eklund, Andrea Discacciati, Tobias Nordström, Rebecca A Hubbard
Journal of Clinical Oncology. 2024-11-10
1 citations
Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis.
Reza Sari Motlagh, Alireza Ghoreifi, Takafumi Yanagisawa, Tatsushi Kawada, Sascha Ahyai
BJU International. 2024-10-01
Radiation-induced Sarcoma of the Prostate After Treatment for Rhabdomyosarcoma.
Diana A Aponte-Colon, Austin Creviston, Michael Abern, Jonathan C Routh
Urology. 2024-07-01

Authored Content

Effect of Blood Transfusions on Oncological Outcomes of Surgically Treated Localized Renal Cell CsarcinomaMay 2018
Effect of Blood Transfusions on Oncological Outcomes of Surgically Treated Localized Renal Cell CsarcinomaMay 2018

Press Mentions

Medtronic’s Hugo Enrolls First US Clinical Trial PatientDecember 15th, 2022

Grant Support

Enhanced diffusion weighted imaging techniques for high grade prostate cancer detectionDepartment of Defense2015–2019

Committees

Chair, AUA Conflict of Interest Committee 2018 - 2020
Vice Chair, AUA Content Review Committee 2016 - 2018

Professional Memberships

Alpha Omega Alpha Honor Medical Society - AOA
Member
American Urological Association - AUA
Member
Society of Urologic Oncology
Member